Before investing in any company I like to do my DD and in particular look at their financials rather than only looking at charts like many TA investors and traders. I am impressed with the DurAVR product, but feel the company is a little over-exuberant in their presentations which I've already detailed and supported with appropriate links. The overly slick (IMO) company presentation which leaves out relevant info is a red flag for me. Pointing out some doubtful points is not down ramping it"s simply investor caution. I've yet to discuss the DurAVR with my cardiologist, but as I'm due for appt soon will certainly value his opinion.
Anteris Channel 9 Interview 2022, page-13
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.31 |
Change
-0.240(1.29%) |
Mkt cap ! $351.9M | |||
| Open | High | Low | Value | Volume |
| $18.80 | $19.15 | $18.20 | $159.7K | 8.611K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73 | $18.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.33 | 90 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |